Hamburg, Germany

Ralf Warratz

This inventor holds 1 USPTO granted patent. Top assignee: Sick Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralf Warratz. Retrieved from https://idiyas.com/inventor/ralf-warratz-ptchcfkf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralf Warratz and Spectroscopic Fluid and Gas Analysis.

Introduction

Ralf Warratz is an inventor associated with Hamburg, Germany, and SICK AG. His listed patent focuses on spectroscopic analysis of fluids and gases using a multi-chamber cuvette.

Latest Patents

Warratz is credited with 1 patent: “Spectroscopic Analysis Apparatus Comprising a Multi-Chamber Cuvette for Fluid or Gas Analysis and Corresponding Method.” The invention describes a cuvette with at least two optically separated measurement chambers. An illumination device directs light into the chambers, while a detection device measures light at different wavelengths to produce separate measurement results. This arrangement supports spectroscopic analysis of fluid or gas samples.

Career Highlights

The available information associates Warratz’s work with SICK AG, a company known for developing sensor and measurement technologies. His listed patent addresses an apparatus and method for analyzing fluids or gases.

Collaborations

Benjamin Hagemann is identified as Warratz’s coworker. The provided information does not specify whether Hagemann collaborated on the patent.

Conclusion

Ralf Warratz’s listed invention applies multi-chamber cuvette design and wavelength-specific measurements to spectroscopic fluid and gas analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…